Silvercrest Asset Management Group LLC Collegium Pharmaceutical, Inc Transaction History

Silvercrest Asset Management Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$21.74 - $25.28 $4.87 Million - $5.66 Million	-223,840 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $572,572 - $776,318	-29,744 Reduced 11.73%	223,840 $5.31 Million
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $769,025 - $961,389	-43,131 Reduced 14.54%	253,584 $5.08 Million
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $88,115 - $116,258	-5,584 Reduced 1.85%	296,715 $6.18 Million
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $82,004 - $124,461	-5,294 Reduced 1.72%	302,299 $5.29 Million
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $718,835 - $1.32 Million	51,752 Added 20.23%	307,593 $5.02 Million
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $2.05 Million - $4.27 Million	-191,857 Reduced 42.85%	255,841 $5.27 Million
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $4.55 Million - $5.95 Million	447,698 New	447,698 $5.14 Million

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.